Clinical Trials
3
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Apixaban + DAPT in Lowering Platelet Reactivity and Thrombin Generation
Completed
- Conditions
- Acute Coronary Syndrome
- First Posted Date
- 2018-11-20
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- CirQuest Labs, LLC
- Target Recruit Count
- 40
- Registration Number
- NCT03746782
- Locations
- 🇺🇸
CirQuest Labs, LLC, Memphis, Tennessee, United States
Assessment of Biomarkers in Patients With Decompensated Heart Failure and Underlying Coronary Artery Disease
- Conditions
- Coronary Artery DiseaseHeart Failure With Reduced Ejection Fraction
- First Posted Date
- 2018-06-11
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- CirQuest Labs, LLC
- Target Recruit Count
- 120
- Registration Number
- NCT03551756
- Locations
- 🇺🇸
University of Florida, Jacksonville, Florida, United States
🇺🇸Stern Cardiovascular, Germantown, Tennessee, United States
🇺🇸CirQuest Labs, LLC, Memphis, Tennessee, United States
A Single Center Study to Evaluate Ticagrelor Mechanism of Action in Inhibiting Juvenile Platelet ADP Response
- First Posted Date
- 2017-01-23
- Last Posted Date
- 2020-07-15
- Lead Sponsor
- CirQuest Labs, LLC
- Registration Number
- NCT03027934
News
No news found